Chad M. Cohen, Chief Financial Officer at Adaptive Biotechnologies Corp (ADPT), sold 199,000 shares at $65.47 ($12.9M) on 2021-01-26, disclosed to the SEC on 2021-01-27.
Open-market sale of $12.9M ADPT by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $65.08 | 10,611 | $691K | 5.3% |
| 2 | $65.08 | 10,611 | $691K | 5.3% |
| 3 | $65.69 | 20,953 | $1.4M | 10.6% |
| 4 | $65.69 | 20,953 | $1.4M | 10.6% |
| 5 | $67.03 | 17,436 | $1.2M | 9.0% |
| 6 | $67.03 | 17,436 |
| $1.2M |
| 9.0% |
| 7 | $67.68 | 1,000 | $68K | 0.5% |
| 8 | $62.71 | 10,318 | $647K | 5.0% |
| 9 | $62.71 | 10,318 | $647K | 5.0% |
| 10 | $63.65 | 12,977 | $826K | 6.4% |
| 11 | $63.65 | 12,977 | $826K | 6.4% |
| 12 | $64.54 | 20,785 | $1.3M | 10.4% |
| 13 | $64.54 | 20,785 | $1.3M | 10.4% |
| 14 | $65.47 | 5,920 | $388K | 3.0% |
| 15 | $65.47 | 5,920 | $388K | 3.0% |
| Total | $65.04 avg | 199,000 | $12.9M | 100% |
| Filing → |
| ADPT | SELL | 2021-10-07 | $324K | — | Filing → |
| ADPT | SELL | 2021-09-09 | $940K | — | Filing → |
| ADPT | SELL | 2021-08-12 | $804K | — | Filing → |